期刊文献+

2D-QSAR Studies on the Norcantharidin Analogues as Protein Phosphatase 1 and 2A Inhibitors 被引量:5

2D-QSAR Studies on the Norcantharidin Analogues as Protein Phosphatase 1 and 2A Inhibitors
下载PDF
导出
摘要 The Two-dimensional Quantitative Structure-activity Relationship (2D-QSAR) of a series of novel norcantharidin analogues, which exhibit hnhibitory activities of protein phosphatase 1 and 2A (PP1 and PP2A), has been studied with a combined method of ab initio (I/F), molecular mechanics (MM+) and statistics. The established 2D-QSAR model (Eq. 1) for PP1 shows a reasonable regressive performance (R2= 0.749), and the hydrophobic property of this molecule plays a decisive role in determining the inhibitory activity of PP1. In addition, the established 2D-QSAR model (Eq. 2) for PP2A also shows an acceptable regressive performance (R2= 0.701), and the dipole moment of the molecule determines the inhibitory activity of PP2A. The Two-dimensional Quantitative Structure-activity Relationship (2D-QSAR) of a series of novel norcantharidin analogues, which exhibit hnhibitory activities of protein phosphatase 1 and 2A (PP1 and PP2A), has been studied with a combined method of ab initio (I/F), molecular mechanics (MM+) and statistics. The established 2D-QSAR model (Eq. 1) for PP1 shows a reasonable regressive performance (R2= 0.749), and the hydrophobic property of this molecule plays a decisive role in determining the inhibitory activity of PP1. In addition, the established 2D-QSAR model (Eq. 2) for PP2A also shows an acceptable regressive performance (R2= 0.701), and the dipole moment of the molecule determines the inhibitory activity of PP2A.
作者 谢惠定
出处 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2009年第5期621-627,共7页 结构化学(英文)
基金 supported by the China Scholarship Council (CSC [2006] No. 3085)
关键词 2D-QSAR norcantharidin analogues inhibitory activities of PP1 and PP2A 2D-QSAR, norcantharidin analogues, inhibitory activities of PP1 and PP2A
  • 相关文献

参考文献15

  • 1Wang, G. S. Journal of Ethnopharmacology 1989, 26, 147-162.
  • 2Deng, L. P.; Shen, L.; Zhang, J.; Yang, B.; He. Q. J.; Hu, Y. Z. Canadian Journal of Chemistry 2007, 85, 938-944.
  • 3Hill, T. A.; Stewart, S. G.; Ackland, S. P.; Gilbert, J., Sauer, B.; Sakoff, J. A.; McCluskey, A. Bioorganic & Medicinal Chemistry 2007, 15, 6126-6134.
  • 4McCluskey, A.; Sakoff, J. A. Mini Reviews in Medicinal Chemistry 2001, 1, 43-55.
  • 5Hill, T. A.; Stewart, S. G; Sauer, B.; Gilbert, J.; Ackland, S. P.; Sakoff, J. A.; McCluskey, A. Bioorganic & Medicinal Chemistry Letters 2007, 17, 3392-3397.
  • 6Stewart, S. G; Hill, T. A.; Gilbert, J.; Ackland, S. P.; Sakoff, J. A.; McCluskey, A. Bioorganic & Medicinal Chemistry 2007, 15, 7301-7310.
  • 7Hart, M. E.; Chamberlin, A. R.; Walkom, C.; Sakoff, J. A.; McCluskey, A. Bioorganic & Medicinal Chemistry Letters 2004, 14, 1969-1973.
  • 8Anon. Classical QSAR: Review, QSAR & Combinatorial Science 2004, 23, 795-821.
  • 9Loew, G. H.; Villar, H. O.; Alkorta, I. Pharmaceutical Research 1993, 10, 475-486.
  • 10Liao, S. Y.; Chen, J. C.; Qian, L.; Shen, Y.; Zheng, K. C. QSAR & Combinatorial Science 2008, 27, 280-288.

同被引文献47

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部